Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis

BACKGROUND: The aim of our study was to investigate the influence of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) and body mass index (BMI) on circulating drug levels and clinical response to tumour necrosis factor inhibitor (TNFi) therapy in axial spondyloarthritis (axSp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Breijo, Borja, Plasencia-Rodríguez, Chamaida, Navarro-Compán, Victoria, Martínez-Feito, Ana, Jochems, Andrea, Kneepkens, Eva L., Wolbink, Gerrit J., Rispens, Theo, Diego, Cristina, Pascual-Salcedo, Dora, Balsa, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383284/
https://www.ncbi.nlm.nih.gov/pubmed/30786913
http://dx.doi.org/10.1186/s13075-019-1849-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383284/
https://www.ncbi.nlm.nih.gov/pubmed/30786913
http://dx.doi.org/10.1186/s13075-019-1849-3

Ejemplares similares